EFFICIENT DIFFERENTIATION, SCALE-UP, AND MATURATION OF IPS DERIVED CARDIOMYOCYTES

IPS 来源的心肌细胞的有效分化、放大和成熟

基本信息

  • 批准号:
    10761485
  • 负责人:
  • 金额:
    $ 27.54万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-09-05 至 2024-08-31
  • 项目状态:
    已结题

项目摘要

Project Summary/Abstract Cell expansion is a critical step for cell therapy, hindered by expensive and complex bioreactor requirements to yield sufficient cell numbers for adequate dosing and requiring expensive regents to enhance functionality for increased clinical success. Similarly, in-vitro models of cardiac disease using induced pluripotent stem cell derived cardiomyocytes (iPS-CM) are of critical importance to understanding cardiac biology and disease in the human setting. However, inefficient differentiations hinder the robust translation of these models from the bench to clinically useful metrics. Similarly, iPS-CMs are inherently immature and represent fetal like phenotoypes more than their adult counterparts of more relevance for clinical utility. Thus, there is a need for the reliable production of iPS-CMs of high quality, yield, and maturity. To address this, Link provides low-shear pumpless perfusion bioreactors contatining organotypic niches for the bulk culture of cells in controllable 3D aggregates for enhanced delivery of nutrients, enhanced efficiency of directed differentiations, and increased viability and yeild due to efficient gas and nutrient exchange. These bioreactors require significantly less media than similar bioreactors and substantially less hand-on culture time than current manual workflows. Our devices are cost efficient and simple to use, democratizing patient modeling and cell therapy for both patients, researchers and providers. The increased efficiency of our developed device enables an increase in the patient pool by improving patient access, availability, and applicability to more disease subtypes.
项目摘要/摘要 细胞扩增是细胞治疗的关键步骤,但昂贵而复杂的生物反应器要求 产生足够的细胞数量以满足足够的剂量,并需要昂贵的试剂来增强功能 提高了临床成功率。同样,使用诱导多能干细胞建立心脏病的体外模型 来源的心肌细胞(iPS-CM)对于了解心脏生物学和心脏疾病具有重要意义。 以人为本。然而,低效的区分阻碍了这些模型在工作台上的稳健转换 到临床有用的指标。同样,iPS-CMS天生不成熟,更多地代表胎儿的表型 比他们的成年同龄人更具有临床实用性。因此,需要可靠的生产 优质、高产、成熟的iPS-CMS。为了解决这个问题,Link提供了低切变率的无泵灌注 在可控3D聚集体中大量培养细胞的接触器型生态位的生物反应器 提供营养,提高定向分化的效率,并提高存活率和产量 高效的气体和养分交换。这些生物反应器比类似的生物反应器所需的介质要少得多。 并且与当前的手动工作流程相比,实际操作培训时间大大减少。我们的设备经济实惠, 简单易用,为患者、研究人员和提供者提供大众化的患者建模和细胞治疗。这个 我们开发的设备提高了效率,通过改善患者准入来增加患者池, 可获得性和对更多疾病亚型的适用性。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Kacey Ronaldson其他文献

Kacey Ronaldson的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Kacey Ronaldson', 18)}}的其他基金

CELL EXPANSION BIOREACTORS FOR ASSAY-READY IMMUNOCOMPETENT PATIENT MODELS
用于检测准备的免疫功能正常患者模型的细胞扩增生物反应器
  • 批准号:
    10688981
  • 财政年份:
    2023
  • 资助金额:
    $ 27.54万
  • 项目类别:
EFFICIENT SCALE-UP OF IPS CELLS FOR AUTOLOGOUS CELL THERAPY WORKFLOW
高效扩大 IPS 细胞的自体细胞治疗工作流程
  • 批准号:
    10822298
  • 财政年份:
    2023
  • 资助金额:
    $ 27.54万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 27.54万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 27.54万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 27.54万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 27.54万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 27.54万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 27.54万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 27.54万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 27.54万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 27.54万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 27.54万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了